This study is testing if combining low-intensity focused ultrasound (LIFU) brain stimulation with immersive virtual reality (IVR) therapy can improve vision problems after a stroke. LIFU uses gentle ultrasound waves to stimulate specific parts of the brain, and IVR uses a VR headset for interactive visual exercises. You might be able to join if you are 18 or older, have had an ischemic or hemorrhagic stroke 6 to 24 months ago, and have a visual field defect (like not being able to see part of your vision). The main goal is to see how much your visual field changes from the start of the study until 30 days after treatment ends. The study plans to enroll 28 people, but its current status is unclear.

Study design

This is an interventional study where participants are randomly assigned to receive either active LIFU plus VR, or inactive LIFU plus VR. Neither you nor the researchers will know which group you are in.

What's involved

Active participation in the study lasts 1.5 months, including 9 intervention sessions over 21 days, each lasting about 2.5 hours.

Compensation

Not stated in the trial record.

Follow-up

Your visual field will be measured from enrollment until 30 days after the end of treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.